The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 351:315-317 July 22, 2004 Number 4
NextNext

Public Registration of Clinical Trials
Robert Steinbrook, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
For many years, the registration in a public data bank of all clinical trials — from start to completion and reporting of results — has seemed a quixotic quest of some academic researchers, medical-journal editors, and librarians. Within the past two months, however, a constellation of events and developments has broadened this effort and captured the attention of the medical profession, the news media, and government officials. The events include a lawsuit against GlaxoSmithKline by New York State Attorney General Eliot Spitzer for concealing negative information about the antidepressant medication paroxetine and the endorsement of a comprehensive registry by the . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.